Tag Archives: venture capital

The ILSI-BioMed Israel Conference Continues to Grow

The 11th annual ILSI-BioMed 2012 Conference, also known as National Life Science and Technology Week, was held in Tel Aviv, Israel on 21-23 May 2012. Throughout the many years of attendance, we’ve seen exciting growth in diverse fields of technology … Continue reading

Posted in Conferences and Meetings, Venture Capital | Tagged , , , , , , , , | Comments Off on The ILSI-BioMed Israel Conference Continues to Grow

Cato Research Canada Celebrates Two Decades of Success in the Drug Development Industry

Over the past 5 years, the life sciences industry throughout Canada, and especially in Québec, has been extensively challenged. Capitalizing on strong relationships built over years with clients and partners has helped Cato Research continue to provide excellent services and weather the industry’s roller coaster ride. On 03 May 2012, Cato Research Canada will celebrate its 20th anniversary with a celebratory wine tasting. You are invited to join us and other industry representatives to talk about the changing climate for pharmaceutical and biotechnology companies in Canada. Continue reading

Posted in Industry News | Tagged , , , , , , , , , , | Comments Off on Cato Research Canada Celebrates Two Decades of Success in the Drug Development Industry

The CED Life Science Conference and Biotech’s Yellow Brick Road

The 21st annual CED Life Science Conference achieved its mission of cementing the Research Triangle Park as a hotbed for innovation and opportunity in biotech.  The 2012 CED LSC showcased local leaders like Victor Dzau, President and CEO of Duke … Continue reading

Posted in Clinical Trials, Conferences and Meetings, FDA, Industry News, Regulatory Strategy | Tagged , , , , , , , , , , , , , , , , , , , | 1 Comment

Bridging the Valley of Death: Bringing New Drugs from the Bench to the Clinic

To bring a new medicine to the stage of clinical trial testing requires on the order of $500,000 to one million dollars and then seven to ten years of clinical trials and around $800 million dollars before getting to market.  … Continue reading

Posted in Clinical Trials, Venture Capital | Tagged , , , , , , , , , , , , | Comments Off on Bridging the Valley of Death: Bringing New Drugs from the Bench to the Clinic

Conference Recap – BayBio 2011

The BayBio Annual Conference 2011 was held on 20-21 April 2011 in Burlingame, CA.  The event was attended by more than 1,000 San Francisco Bay Area biotech and life sciences professionals from over 400 companies. This year’s conference focused on … Continue reading

Posted in Conferences and Meetings, Venture Capital | Tagged , , , , , , , , , , , , , , , , , | Comments Off on Conference Recap – BayBio 2011